| Similar Articles |
|---|
 |
The Motley Fool
August 4, 2006
Stephen D. Simpson |
SilverHawk Flying Just Fine, Thanks With med-tech company FoxHollow Technologies, there is growth and risk in equal measure. Investors, take note.   |
The Motley Fool
February 27, 2006
Stephen D. Simpson |
A Foxy Idea? Medical device maker Foxhollow is in an attractive niche, but management turnover is a reason for investors to worry. |
The Motley Fool
May 9, 2005
Stephen D. Simpson |
Integra LifeSciences Strikes a Nerve The med-tech company's missed quarter coupled with some slightly disappointing guidance caused investors to lose a bit of faith, sending the shares down more than 15% at one point. |
The Motley Fool
January 30, 2006
Stephen D. Simpson |
Don't Hold Your Breath for Kensey Nash It's not over for Kensey Nash -- it will soon be seeing revenue from new partners Medtronic and Zimmer. But the stock's price continues to value this company as a growing med-tech idea. |
The Motley Fool
November 9, 2006 |
FoxHollow Technologies: Fool by Numbers The med-tech company released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
March 2, 2005
Stephen D. Simpson |
CardioDynamics' Palpitations The small-cap medical device maker has a good device, but driving growth is a bit tougher. An investment in CardioDynamics will be an exercise in patience. |
The Motley Fool
May 8, 2006
Stephen D. Simpson |
A Firm Backbone at Kyphon Medtronic begins a lawsuit, but Kyphon should continue to grow. However, these shares are on the expensive side, even for a fast-growing med-tech company. |
The Motley Fool
July 26, 2006
Stephen D. Simpson |
Aspect Gives Investors Nightmares The med tech company continues to grow, but high volatility is likely to follow. |
The Motley Fool
June 30, 2006
Stephen D. Simpson |
Arrow's Erratic Flight Progress for the med-tech is still slow in coming, though market rewards have come faster. Investors, take note. |
The Motley Fool
January 30, 2006
Stephen D. Simpson |
A Bard's Tale The advanced medical technology company's stock already reflects new products' potential. Still, life in the med-tech sector could get more interesting in the coming quarters. Investors, take note. |
The Motley Fool
August 23, 2006
Stephen D. Simpson |
Is Medtronic Sweeping the Deck? Nothing's changing at a deep fundamental level in health care that would impede the growth of this giant med-tech corporation. However, investors need to proceed with caution. |
The Motley Fool
February 15, 2007
Billy Fisher |
Taking FoxHollow's Pulse The medical-device maker gets a checkup from the market. Results were mixed, although the stock was trading down 4%. |
The Motley Fool
July 27, 2005
Stephen D. Simpson |
Back Pain for Shorts? Kyphon continues to defy its skeptics. A developer of minimally invasive technology for the spine, the company saw revenue in the second quarter grow 48% as the U.S. business grew about 41% and overseas sales climbed 99%. Investors, take note. |
The Motley Fool
October 19, 2005
Stephen D. Simpson |
ICU, You Look Healthier An incredible third quarter shows what operating leverage can do for this little medical technology company. Investors, take note. |
The Motley Fool
March 15, 2006
Rich Smith |
Foolish Forecast: New York, New Year Analysts are looking for clothier New York & Co. to hit the top of its latest guidance of $0.33 to $0.36 per share for the quarter. That 9% increase might be a bit optimistic, however, in light of the already confirmed "revenue miss." |
The Motley Fool
November 10, 2006
Billy Fisher |
FoxHollow Taken to the Cleaners The medical-device maker's reduced guidance leaves investors steamed. |
The Motley Fool
August 21, 2006
Stephen D. Simpson |
Kensey Nash Losing the Benefit of the Doubt Med-tech investors won't wait indefinitely for growth. Investors can find better values in this sector if they're willing to roll up their sleeves for some due diligence. |
The Motley Fool
September 29, 2006
Brian Lawler |
Merck Likes FoxHollow The pharmaceutical giant signs another collaborative research agreement with the small-cap company. Investors, take note. |
The Motley Fool
July 5, 2006
Glenn Brandys |
FoxHollow's SilverHawk Won't Soar Cost, time, and competition are holding back the med-tech's device for treating artery disease. Investors, take note. |
The Motley Fool
February 20, 2007 |
FoxHollow Technologies Breathing OK: Fool by Numbers The medical device maker released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
May 4, 2007
Billy Fisher |
In Search of New Prey at FoxHollow The medical device maker reported a 6% increase in revenues on a year-over-year basis for its first-quarter. Investors, take note. |
The Motley Fool
April 24, 2006
Stephen D. Simpson |
Kensey Nash: Now the Comeback Kid? Strong results from a new device might be reason for optimism. Investors should still keep an eye on the valuations here and err on the side of cheapness. |
The Motley Fool
January 26, 2007
Matthew Crews |
Bard's Costly Quarter? The medical device company suffered from multiple one-time charges. Investors who've seen the cup as half full have fared much better here than with many other med-tech companies. |
The Motley Fool
May 2, 2007 |
Product Revenue Falls at FoxHollow Technologies: Fool by Numbers The medical device maker released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
July 3, 2006
Stephen D. Simpson |
Encore Takes Final Bow Encore Medical, a med-tech company that could never quite get going, sells out to a private investor. Investors, take note. |
The Motley Fool
August 18, 2005
Stephen D. Simpson |
Kensey Nash Needs to Kick It Up The med-tech company must deliver profit growth if it is to grow or maintain its valuation. |
The Motley Fool
September 13, 2005
Stephen D. Simpson |
Best Buy Almost a Buy Don't let wobbly quarterly guidance chase you away from one of the best retailers around. |
The Motley Fool
April 21, 2006
Stephen D. Simpson |
Bard Rolls On Nothing flashy here, but at the right price, this would be an interesting med-tech play. Investors, take note. |
The Motley Fool
November 12, 2004
Chuck Saletta |
Three Magical Words Margin of safety are the three most important words in value investing. |
The Motley Fool
May 4, 2006
Stephen D. Simpson |
Aspect Won't Put You to Sleep High valuation of this med-tech company all but guarantees that the stock will see some volatility. |
The Motley Fool
October 31, 2005
Stephen D. Simpson |
Integra Needs to Grow From Within Acquired growth is nice, but organic growth is the key to long-term success. Quite frankly, the only way this stock works from a cash flow valuation standpoint is if the company does in fact deliver very good growth over the next 10 years or so. |
The Motley Fool
December 29, 2006
Matthew Crews |
FoxHollow: Scale Is Critical Can this medical-device maker be a long-term success, or is it just a one-hit wonder? Investors, take note. |
The Motley Fool
April 20, 2006
Stephen D. Simpson |
More Predictable Unpredictability at ICU Hidden beneath all of the volatility is a pretty decent med-tech business. Recent volatility was the kind that investors like. The stock spiked up as earnings exceeded analyst estimates and the business did a fair bit better than management had projected at the end of last quarter. |
The Motley Fool
April 17, 2007
Brian Lawler |
Merck Raises the Earnings Roof Shares of Merck soar after it raises 2007 earnings guidance. |
